Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy (Q35076856)

6 August 2017

Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy (English)

1 reference

6 August 2017

Peter K Kaiser

2

0 references

Darius M Moshfeghi

1

object named as

Darius M Moshfeghi

1 reference

6 August 2017

Mark W Johnson

6

1 reference

ORCID Public Data File 2021

author name string

Hans E Grossniklaus

3

1 reference

6 August 2017

Paul Sternberg

4

1 reference

6 August 2017

Jonathan E Sears

5

1 reference

6 August 2017

Norman Ratliff

7

1 reference

6 August 2017

Andre Branco

8

1 reference

6 August 2017

Mark S Blumenkranz

9

1 reference

6 August 2017

Hilel Lewis

10

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

American Journal of Ophthalmology

6 August 2017

1 reference

6 August 2017

135

1 reference

6 August 2017

3

1 reference

6 August 2017

343-350

1 reference

Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901936-0

Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901936-0

Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901936-0

A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901936-0

Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901936-0

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynami

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901936-0

Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901936-0

Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901936-0

Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901936-0

Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901936-0

Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901936-0

Clinicopathologic features of surgically excised choroidal neovascular membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901936-0

Clinicopathologic correlations of surgically excised type 1 and type 2 submacular choroidal neovascular membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901936-0

Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901936-0

Clinicopathologic studies of age-related macular degeneration with classic subfoveal choroidal neovascularization treated with photodynamic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901936-0

Histological findings of surgically excised choroidal neovascular membranes after photodynamic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901936-0

Photochemical initiation of thrombosis. Fluorescein angiographic, histologic, and ultrastructural alterations in the choroid, retinal pigment epithelium, and retina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901936-0

Experimental studies of indocyanine green dye-enhanced photocoagulation of choroidal neovascularization feeder vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901936-0

Theoretical investigation of the role of choriocapillaris blood flow in treatment of subfoveal choroidal neovascularization associated with age-related macular degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901936-0

10.1016/S0002-9394(02)01936-0

7 January 2021

Identifiers

DOI

1 reference

6 August 2017

1 reference